To assess the antitumor efficacy of recombinant VVs, 4T1 tumor-bearing mice received intratumoral injections of PBS, VV-Ctrl, VV-Ctrl-BiTE or VV-EpCAM BiTE (Figure 3A). This evidence concerns the gene EPCAM and neoplasm.